-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
PetVivo (OTCMKTS:PETV) Shares Cross Above 50 Day Moving Average of $2.23
PetVivo (OTCMKTS:PETV) Shares Cross Above 50 Day Moving Average of $2.23
PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $2.23 and traded as high as $2.59. PetVivo shares last traded at $2.41, with a volume of 18,760 shares changing hands.
PetVivo Price Performance
The stock has a fifty day moving average of $2.23 and a 200-day moving average of $2.00. The company has a quick ratio of 4.00, a current ratio of 4.15 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $24.27 million, a P/E ratio of -3.21 and a beta of 1.91.
Get PetVivo alerts:PetVivo (OTCMKTS:PETV – Get Rating) last released its quarterly earnings results on Thursday, August 11th. The company reported ($0.20) earnings per share (EPS) for the quarter. PetVivo had a negative net margin of 3,817.65% and a negative return on equity of 99.68%. The business had revenue of $0.06 million during the quarter.
Institutional Trading of PetVivo
A hedge fund recently bought a new stake in PetVivo stock. Truist Financial Corp bought a new position in shares of PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 139,803 shares of the company's stock, valued at approximately $221,000. Truist Financial Corp owned 1.40% of PetVivo at the end of the most recent quarter. Institutional investors and hedge funds own 12.90% of the company's stock.About PetVivo
(Get Rating)
PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
Featured Articles
- Get a free copy of the StockNews.com research report on PetVivo (PETV)
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
- Is Lyft Going To Make It As Acquisition Rumors Swirl?
- Four Cheap Stocks With Interesting Insider Activity
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $2.23 and traded as high as $2.59. PetVivo shares last traded at $2.41, with a volume of 18,760 shares changing hands.
PetVivo控股公司(OTCMKTS：PETV-GET評級)在週三的交易中突破了50日移動均線。該股的50日移動均線為2.23美元，交易價格高達2.59美元。PetVivo的股票最後報2.41美元，成交量為18,760股。
PetVivo Price Performance
PetVivo性價比
The stock has a fifty day moving average of $2.23 and a 200-day moving average of $2.00. The company has a quick ratio of 4.00, a current ratio of 4.15 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $24.27 million, a P/E ratio of -3.21 and a beta of 1.91.
該股的50日移動均線切入位為2.23美元，200日移動均線切入位為2.00美元。該公司的速動比率為4.00，流動比率為4.15，債務權益比率為0.01。該公司的市值為2427萬美元，市盈率為-3.21，貝塔係數為1.91。
PetVivo (OTCMKTS:PETV – Get Rating) last released its quarterly earnings results on Thursday, August 11th. The company reported ($0.20) earnings per share (EPS) for the quarter. PetVivo had a negative net margin of 3,817.65% and a negative return on equity of 99.68%. The business had revenue of $0.06 million during the quarter.
PetVivo(OTCMKTS：PETV-GET Rating)上一次發佈季度收益報告是在8月11日星期四。該公司公佈了該季度每股收益(EPS)(0.20美元)。PetVivo的淨利潤率為負3817.65%，股本回報率為負99.68%。該業務在本季度的收入為60萬美元。
Institutional Trading of PetVivo
PetVivo的機構交易
About PetVivo
關於PetVivo
(Get Rating)
(獲取評級)
PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
PetVivo控股公司是一家生物醫療設備公司，從事治療動物疾病和疾病的醫療設備和生物材料的製造、商業化和許可。它的主要產品是Spryng，一種由獸醫管理的關節內注射，用於治療跛行和其他關節疾病，如狗和馬的骨關節炎。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on PetVivo (PETV)
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
- Is Lyft Going To Make It As Acquisition Rumors Swirl?
- Four Cheap Stocks With Interesting Insider Activity
- 免費獲取StockNews.com關於PetVivo的研究報告(PETV)
- 這家醫療設備製造商準備好繼續反彈了嗎？
- 第三季度財報公佈前最值得關注的五(5)只股票
- Take-Two Interactive是否已經退化為一招小馬？
- 隨着收購傳言的甚囂塵上，Lyft能否成功？
- 具有有趣內幕活動的四隻廉價股票
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
接受PetVivo Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對PetVivo和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧